A new paradigm in the treatment of carcinoma: specific molecular targeting.
D018263:Adenocarcinoma, Follicular / Q000188:drug therapy*; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D013964:Thyroid Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D011505:Protein-Tyrosine Kinases